Detalhe da pesquisa
1.
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021.
J Eur Acad Dermatol Venereol
; 37 Suppl 1: 14-19, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36546465
2.
Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel.
J Drugs Dermatol
; 21(3): 242-248, 2022 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35254765
3.
A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream.
J Drugs Dermatol
; 20(4): 420-425, 2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33852251
4.
Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology.
Dermatol Ther (Heidelb)
; 13(8): 1763-1771, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37351830
5.
Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp.
Drugs Context
; 122023.
Artigo
Inglês
| MEDLINE | ID: mdl-36968458
6.
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies.
Dermatol Ther (Heidelb)
; 13(9): 2031-2044, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37490268
7.
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review.
Dermatol Ther (Heidelb)
; 13(10): 2153-2169, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37740858
8.
Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application.
Dermatol Ther (Heidelb)
; 12(10): 2217-2231, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36050567
9.
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis.
J Dermatolog Treat
; 33(8): 3191-3198, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36036596
10.
Validation of the Self-Reported Psoriasis Treatment Convenience Scale (PTCS).
Dermatol Ther (Heidelb)
; 11(6): 2077-2088, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34648147
11.
Profiling of multiple signal pathway activities by multiplexing antibody and GFP-based translocation assays.
Comb Chem High Throughput Screen
; 11(7): 537-44, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18694390
12.
High content translocation assays for pathway profiling.
Methods Mol Biol
; 356: 401-14, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-16988419
13.
Protein translocation assays: key tools for accessing new biological information with high-throughput microscopy.
Methods Enzymol
; 414: 513-30, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17110209
14.
Identification of RAS-mitogen-activated protein kinase signaling pathway modulators in an ERF1 redistribution screen.
J Biomol Screen
; 11(4): 423-34, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16751337
15.
A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions.
Assay Drug Dev Technol
; 4(6): 679-88, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17199506
16.
Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer.
J Biomol Screen
; 10(1): 20-9, 2005 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15695340
17.
Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
Cell Signal
; 15(10): 955-71, 2003 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-12873709
18.
Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen.
Assay Drug Dev Technol
; 2(1): 7-20, 2004 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-15090206
19.
Topical cyclosporin A as a steroid-sparing agent for ocular rosacea.
Acta Ophthalmol
; 95(2): e158-e159, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27312057